Home › Macular Degeneration › California › San Francisco
Macular Degeneration clinical trials in San Francisco, CA
5 studies for Macular Degeneration are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- West Coast Retina Medical Group, Inc., San Francisco
Village-Integrated Eye Worker Trial II
RecruitingHealthy volunteers welcome
- University of California, San Francisco, San Francisco
Strategies for Improving Linkage-to-Care After Eye Disease Screening
Recruiting
- University of California, San Francisco, San Francisco
Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
RecruitingObservational study
- University of California, San Francisco, San Francisco
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
RecruitingPhase 3
- West Coast Retina Medical Group, San Francisco
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Reno, NV8 studies
- Sacramento, CA8 studies
- Hagerstown, MD8 studies
- Cleveland, OH7 studies
- Fort Worth, TX7 studies
- Carmel, IN7 studies
- Salt Lake City, UT7 studies
- Austin, TX7 studies
- Houston, TX7 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.